Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency [ID6415]

  • In development
  • GID-TA11503
  • Expected publication date: 

NIHRIO BN: 37641-Dostarlimab-Paclitaxel-Carboplatin-for-Endometrial-Cancer-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)